217 related articles for article (PubMed ID: 7657128)
1. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome.
Riegler JL; Lang KA; Johnson SP; Westerman JH
Gastroenterology; 1995 Sep; 109(3):978-83. PubMed ID: 7657128
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome.
Selim KM; Akriviadis EA; Zuckerman E; Chen D; Reynolds TB
Am J Gastroenterol; 1998 Mar; 93(3):455-8. PubMed ID: 9517657
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation.
Benítez C; Arrese M; Jorquera J; Godoy I; Contreras A; Loyola S; Domínguez P; Jarufe N; Martínez J; Pérez-Ayuso RM
Ann Hepatol; 2009; 8(1):71-4. PubMed ID: 19221539
[TBL] [Abstract][Full Text] [Related]
4. Hepatopulmonary syndrome.
Koch DG; Fallon MB
Clin Liver Dis; 2014 May; 18(2):407-20. PubMed ID: 24679503
[TBL] [Abstract][Full Text] [Related]
5. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome.
Lasch HM; Fried MW; Zacks SL; Odell P; Johnson MW; Gerber DA; Sandhu FS; Fair JH; Shrestha R
Liver Transpl; 2001 Feb; 7(2):147-9. PubMed ID: 11172400
[TBL] [Abstract][Full Text] [Related]
6. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation.
Ring EJ; Lake JR; Roberts JP; Gordon RL; LaBerge JM; Read AE; Sterneck MR; Ascher NL
Ann Intern Med; 1992 Feb; 116(4):304-9. PubMed ID: 1733385
[TBL] [Abstract][Full Text] [Related]
7. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
Therapondos G; Wong F
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
[TBL] [Abstract][Full Text] [Related]
8. Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.
Tsauo J; Zhao H; Zhang X; Ma H; Jiang M; Weng N; Li X
Eur Radiol; 2019 Jun; 29(6):3273-3280. PubMed ID: 30506220
[TBL] [Abstract][Full Text] [Related]
9. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
10. Hepatopulmonary syndrome. A review of the literature.
Ghittoni G; Valentini G; Spada C; Rossi Z; Gasbarrini G
Panminerva Med; 2003 Jun; 45(2):95-8. PubMed ID: 12855933
[TBL] [Abstract][Full Text] [Related]
11. Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
Nistal MW; Pace A; Klose H; Benten D; Lohse AW
Thorax; 2013 Sep; 68(9):889-90. PubMed ID: 22382598
[No Abstract] [Full Text] [Related]
12. Hepatopulmonary syndrome and liver transplantation: a review of the peroperative management of seven paediatric cases.
Van Obbergh LJ; Carlier M; De Kock M; Otte JB; Moulin D; Veyckemans F
Paediatr Anaesth; 1998; 8(1):59-64. PubMed ID: 9483600
[TBL] [Abstract][Full Text] [Related]
13. Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: A Prospective Study.
Tsauo J; Zhao H; Zhang X; Ma H; Jiang M; Weng N; Li X
J Vasc Interv Radiol; 2019 Feb; 30(2):170-177. PubMed ID: 30717947
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
[TBL] [Abstract][Full Text] [Related]
15. [Hepatopulmonary syndrome].
Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt for a wait list patient is not a contraindication for orthotopic liver transplant outcomes.
Levi Sandri GB; Lai Q; Lucatelli P; Melandro F; Guglielmo N; Mennini G; Berloco PB; Fanelli F; Salvatori FM; Rossi M
Exp Clin Transplant; 2013 Oct; 11(5):426-8. PubMed ID: 23745783
[TBL] [Abstract][Full Text] [Related]
17. Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure.
Wallace MC; James AL; Marshall M; Kontorinis N
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22669921
[TBL] [Abstract][Full Text] [Related]
18. An unusual cause of refractory hypoxemia in cirrhosis.
Patidar Y; Kumar S
Respir Care; 2015 Mar; 60(3):e49-51. PubMed ID: 25316890
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation.
Saad NE; Lee DE; Waldman DL; Saad WE
J Vasc Interv Radiol; 2007 Dec; 18(12):1576-80. PubMed ID: 18057294
[TBL] [Abstract][Full Text] [Related]
20. Late resolution of hepatopulmonary syndrome after liver transplantation.
Philit F; Wiesendanger T; Gille D; Boillot O; Cordier JF
Respiration; 1997; 64(2):173-5. PubMed ID: 9097356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
